Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IVF hartmann Holding AGXSWX:VBSN -0.73%74 Equity-to-Asset is 0.80 as of Jun. 2026, which is 1% below its 10-year median of 0.81. GuruFocus rates XSWX:VBSN with a GF Score™ of 74/100 and a GF Value™ of CHF149.70 (Fairly Valued). Among 851 Medical Devices & Instruments companies, IVF hartmann Holding AG ranks better than 74.03% on this metric.
The historical rank and industry rank for IVF hartmann Holding AG's Equity-to-Asset or its related term are showing as below:
XSWX:VBSN'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.77 Med: 0.81 Max: 0.85
Current: 0.8
During the past 13 years, the highest Equity to Asset Ratio of IVF hartmann Holding AG was 0.85. The lowest was 0.77. And the median was 0.81.
XSWX:VBSN's Equity-to-Asset is ranked better than 74.03% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs XSWX:VBSN: 0.80
IVF hartmann Holding AG (XSWX:VBSN) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
IVF hartmann Holding AG Equity-to-Asset Related Terms
IVF hartmann Holding AG Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:VBSN vs ISRG, BDX, MDLN: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, IVF hartmann Holding AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVF hartmann Holding AG Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, IVF hartmann Holding AG's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where IVF hartmann Holding AG's Equity-to-Asset falls into.
IVF hartmann Holding AG Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
IVF hartmann Holding AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVF hartmann Holding AG (XSWX:VBSN) has a Equity-to-Asset of 0.80 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on IVF hartmann Holding AG and its competitors. This is near median its historical median of 0.81. Over the past decade, IVF hartmann Holding AG's Equity-to-Asset has ranged from 0.77 to 0.85. According to the industry distribution chart, IVF hartmann Holding AG ranks #221 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 26%.
Is IVF hartmann Holding AG's Equity-to-Asset too high?
IVF hartmann Holding AG's current Equity-to-Asset of 0.80 is near median its 10-year median of 0.81. Over the past 10 years, this metric has ranged from a low of 0.77 to a high of 0.85. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. IVF hartmann Holding AG's value of 0.80 is 25% above this industry median. Based on the distribution chart, IVF hartmann Holding AG ranks #221 out of 851 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, IVF hartmann Holding AG has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's Equity-to-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, IVF hartmann Holding AG ranks #221 out of 851 companies for Equity-to-Asset. This puts IVF hartmann Holding AG in the upper half of its industry. The industry median Equity-to-Asset is 0.64. IVF hartmann Holding AG's value of 0.80 is 25% above this benchmark. Historically, IVF hartmann Holding AG's own Equity-to-Asset has ranged from 0.77 to 0.85 over the past decade. While the company's 10-year median is 0.81 vs. the industry median of 0.64, IVF hartmann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IVF hartmann Holding AG's current Equity-to-Asset of 0.80 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on IVF hartmann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IVF hartmann Holding AG's current Equity-to-Asset is 0.80, which is near median its own 10-year median of 0.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (XSWX:VBSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF149.70, compared to a current price of CHF136.00 — trading 9.2% below its estimated fair value. The current Equity-to-Asset is 0.80, which is near median its 10-year median of 0.81 and 25% above the Medical Devices & Instruments industry median of 0.64. IVF hartmann Holding AG's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For IVF hartmann Holding AG (XSWX:VBSN), the current Equity-to-Asset is 0.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IVF hartmann Holding AG (XSWX:VBSN) Overvalued in 2026?
Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued.
The current stock price of CHF136.00 is trading 9.2% below its estimated GF Value™ of CHF149.70.
GuruFocus considers IVF hartmann Holding AG to be Fairly Valued.
Key valuation signals for XSWX:VBSN:
Equity-to-Asset: 0.80 (near median its 10-year median of 0.81)
GF Value™: CHF149.70 vs. price of CHF136.00 (9.2% below fair value)
Industry Position: 25% above the Medical Devices & Instruments median (#221 of 851)
No single metric tells the full story. See the XSWX:VBSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
74GF Score
Get the complete analysis for XSWX:VBSN
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:VBSN has been successfully added to your 
